Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer
SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 -- Kronos Bio, Inc. , a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by...
Source: marketscreener.com